In Tianjin, China, on April 14, 2026, Asymchem, a leading global contract development and manufacturing organization (CDMO), introduced a comprehensive commercial supply framework for TIDES (Peptides and Oligonucleotides) at its TJ4 facility. This initiative merges increased API manufacturing capabilities.